SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Procyon Biopharma Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: thebeach who wrote (337)11/12/2002 6:23:53 PM
From: thebeach  Read Replies (1) of 356
 
“This agreement brings all of the relevant technologies and patents under one roof and allows us to move forward with a product that we know is promising as a first-line detector for colorectal cancer,” said Dr. Brent Norton, President and CEO of IMI. “By integrating some of the beneficial features of COLOPATH(R) with ColorectAlert(TM), we expect the result may be a product that offers even more improvements over existing screening tests.”
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News